Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) (Neuropsychopharmacology, (2020), 45, 10, (1656-1663), 10.1038/s41386-020-0738-4)

Diego A. Pizzagalli; Moria Smoski; Yuen Siang Ang; Alexis E. Whitton; Gerard Sanacora; Sanjay J. Mathew; John Nurnberger; Sarah H. Lisanby; Dan V. Iosifescu; James W. Murrough; Hongqiu Yang; Richard D. Weiner; Joseph R. Calabrese; Wayne Goodman; William Z. Potter; Andrew D. Krystal

doi:10.1038/s41386-021-01145-9

Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) (Neuropsychopharmacology, (2020), 45, 10, (1656-1663), 10.1038/s41386-020-0738-4)

Diego A. Pizzagalli, Moria Smoski, Yuen Siang Ang, Alexis E. Whitton, Gerard Sanacora, Sanjay J. Mathew, John Nurnberger, Sarah H. Lisanby, Dan V. Iosifescu, James W. Murrough, Hongqiu Yang, Richard D. Weiner, Joseph R. Calabrese, Wayne Goodman, William Z. Potter, Andrew D. Krystal

Research output: Contribution to journal › Comment/debate

Abstract

In this article a conflict of interest was missing. The co-author Sanjay J. Mathew served as a consultant to Alkermes. The original article has been corrected.

Original language	English
Pages (from-to)	2224
Number of pages	1
Journal	Neuropsychopharmacology
Volume	46
Issue number	12
DOIs	https://doi.org/10.1038/s41386-021-01145-9
State	Published - Nov 2021

Access to Document

10.1038/s41386-021-01145-9

Fingerprint

Dive into the research topics of 'Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) (Neuropsychopharmacology, (2020), 45, 10, (1656-1663), 10.1038/s41386-020-0738-4)'. Together they form a unique fingerprint.

Cite this

Pizzagalli, D. A., Smoski, M., Ang, Y. S., Whitton, A. E., Sanacora, G., Mathew, S. J., Nurnberger, J., Lisanby, S. H., Iosifescu, D. V., Murrough, J. W., Yang, H., Weiner, R. D., Calabrese, J. R., Goodman, W., Potter, W. Z., & Krystal, A. D. (2021). Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) (Neuropsychopharmacology, (2020), 45, 10, (1656-1663), 10.1038/s41386-020-0738-4). Neuropsychopharmacology, 46(12), 2224. https://doi.org/10.1038/s41386-021-01145-9

Pizzagalli, Diego A. ; Smoski, Moria ; Ang, Yuen Siang et al. / Correction to : Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) (Neuropsychopharmacology, (2020), 45, 10, (1656-1663), 10.1038/s41386-020-0738-4). In: Neuropsychopharmacology. 2021 ; Vol. 46, No. 12. pp. 2224.

@article{3c5bfde40c8644a8bcc39e54df81f79d,

title = "Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) (Neuropsychopharmacology, (2020), 45, 10, (1656-1663), 10.1038/s41386-020-0738-4)",

abstract = "In this article a conflict of interest was missing. The co-author Sanjay J. Mathew served as a consultant to Alkermes. The original article has been corrected.",

author = "Pizzagalli, {Diego A.} and Moria Smoski and Ang, {Yuen Siang} and Whitton, {Alexis E.} and Gerard Sanacora and Mathew, {Sanjay J.} and John Nurnberger and Lisanby, {Sarah H.} and Iosifescu, {Dan V.} and Murrough, {James W.} and Hongqiu Yang and Weiner, {Richard D.} and Calabrese, {Joseph R.} and Wayne Goodman and Potter, {William Z.} and Krystal, {Andrew D.}",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to American College of Neuropsychopharmacology.",

year = "2021",

month = nov,

doi = "10.1038/s41386-021-01145-9",

language = "English",

volume = "46",

pages = "2224",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Nature Publishing Group",

number = "12",

}

Pizzagalli, DA, Smoski, M, Ang, YS, Whitton, AE, Sanacora, G, Mathew, SJ, Nurnberger, J, Lisanby, SH, Iosifescu, DV, Murrough, JW, Yang, H, Weiner, RD, Calabrese, JR, Goodman, W, Potter, WZ & Krystal, AD 2021, 'Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) (Neuropsychopharmacology, (2020), 45, 10, (1656-1663), 10.1038/s41386-020-0738-4)', Neuropsychopharmacology, vol. 46, no. 12, pp. 2224. https://doi.org/10.1038/s41386-021-01145-9

Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) (Neuropsychopharmacology, (2020), 45, 10, (1656-1663), 10.1038/s41386-020-0738-4). / Pizzagalli, Diego A.; Smoski, Moria; Ang, Yuen Siang et al.
In: Neuropsychopharmacology, Vol. 46, No. 12, 11.2021, p. 2224.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) (Neuropsychopharmacology, (2020), 45, 10, (1656-1663), 10.1038/s41386-020-0738-4)

AU - Pizzagalli, Diego A.

AU - Smoski, Moria

AU - Ang, Yuen Siang

AU - Whitton, Alexis E.

AU - Sanacora, Gerard

AU - Mathew, Sanjay J.

AU - Nurnberger, John

AU - Lisanby, Sarah H.

AU - Iosifescu, Dan V.

AU - Murrough, James W.

AU - Yang, Hongqiu

AU - Weiner, Richard D.

AU - Calabrese, Joseph R.

AU - Goodman, Wayne

AU - Potter, William Z.

AU - Krystal, Andrew D.

PY - 2021/11

Y1 - 2021/11

N2 - In this article a conflict of interest was missing. The co-author Sanjay J. Mathew served as a consultant to Alkermes. The original article has been corrected.

AB - In this article a conflict of interest was missing. The co-author Sanjay J. Mathew served as a consultant to Alkermes. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85112681663&partnerID=8YFLogxK

U2 - 10.1038/s41386-021-01145-9

DO - 10.1038/s41386-021-01145-9

M3 - Comment/debate

C2 - 34389811

AN - SCOPUS:85112681663

SN - 0893-133X

VL - 46

SP - 2224

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

IS - 12

ER -

Pizzagalli DA, Smoski M, Ang YS, Whitton AE, Sanacora G, Mathew SJ et al. Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) (Neuropsychopharmacology, (2020), 45, 10, (1656-1663), 10.1038/s41386-020-0738-4). Neuropsychopharmacology. 2021 Nov;46(12):2224. doi: 10.1038/s41386-021-01145-9